Q1 2020

Filed Apr 21, 2020 · 10-Q · 21 days after period end · 0001493152-20-006856

Q1 2020 · 10-Q

Revenue—

Net Income

-$3.05M

N/M vs Q1 2019

EPS Diluted

$0.00

— vs Q1 2019

Operating Income-$2,964,664N/M

Operating Cash Flow-$372,613N/M

Same quarter

Metric	Q1 2020	Q1 2019	Q1 2018	Q1 2017
Revenue	—	$0.00	$108.63K	$0.00
Net Income	-$3.05M	-$477.75K	-$278.93K	-$494.61K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR